Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

STR genotyping diagnosis of hydatidiform moles: an assessment of 2871 consecutive products of conceptions.

Virchows Archiv : an international journal of pathology·2025
Same author

Corrigendum to "Inactivation of Minar2 in mice hyperactivates mTOR signaling and results in obesity" [Mol Metabol 73 (July 2023) 101744].

Molecular metabolism·2025
Same author

Proteomic and phosphoproteomic identified structural and functional changes in the aorta associate with age-dependent hypertension in male Sprague Dawley rats.

Physiological genomics·2024
Same author

Calreticulin Regulates SARS-CoV-2 Spike Protein Turnover and Modulates SARS-CoV-2 Infectivity.

Cells·2023
Same author

Inactivation of Minar2 in mice hyperactivates mTOR signaling and results in obesity.

Molecular metabolism·2023
Same author

Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined Significance.

The journal of applied laboratory medicine·2023

Related Experiment Video

Updated: May 28, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Leukemic Non-Nodal Mantle Cell Lymphoma Presenting with Traumatic Splenic Rupture.

Moinul Haque1, Razie Amraei1, Krasimira A Rozenova1

  • 1Department of Pathology, Yale University School of Medicine, New Haven, CT 06510, USA.

Hematology Reports
|May 27, 2026
PubMed
Summary

Leukemic non-nodal mantle cell lymphoma (nnMCL) can present with isolated splenomegaly and anemia. Diagnosis requires integrating clinical, flow cytometry, imaging, and molecular data, especially in elderly patients.

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Leukemic non-nodal variant mantle cell lymphoma (nnMCL) is a rare subtype characterized by lack of lymphadenopathy and indolent course.
Keywords:
cyclin D1non-nodal mantle cell lymphomaspleen

More Related Videos

Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions
02:09

Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions

Published on: December 20, 2024

Related Experiment Videos

Last Updated: May 28, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions
02:09

Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions

Published on: December 20, 2024

  • Adverse genetic alterations like TP53 inactivation and del(13q) are significant prognostic factors.
  • Splenomegaly can be a key clinical indicator for nnMCL, necessitating further investigation.